Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Shah

Showing results (261-270 of 296) with videos related to

Pageof 30
Sort By:
JCO Precision Oncology|March 30, 2026
Efficacy of Immune Checkpoint Blockade in Advanced Upper Tract Urothelial Cancer With DNA Mismatch Repair Deficiency or Microsatellite InstabilityMohammad Jad Moussa, Alexander Y Andreev-Drakhlin, Aradhana M Venkatesan, et al.
Plos Genetics|September 5, 2014
Histone methyltransferase MMSET/NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylationRelja Popovic, Eva Martinez-Garcia, Eugenia G Giannopoulou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 25, 2025
Final analysis of nivolumab plus cabozantinib for advanced renal cell carcinoma from the randomized phase III CheckMate 9ER trialR J Motzer, B Escudier, M Burotto, et al.
BJU International|November 19, 2016
Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative studyAmishi Y Shah, Jose A Karam, Gabriel G Malouf, et al.
Cancer Medicine|January 20, 2025
Histopathologic Progression and Metastatic Relapse Outcomes in Small Cell Neuroendocrine Carcinomas of the Urinary TractMohammad Jad Moussa, Georges C Tabet, Arlene O Siefker-Radtke, et al.
The Medical Journal of Malaysia|August 20, 2019
Administration of tranexamic acid for victims of severe trauma within pre-hospital care ambulance services (PHCAS) in MalaysiaM Y Shah Jahan, M A Shamila, N Nurul Azlean, et al.
Cell Death and Differentiation|September 17, 2013
HINCUTs in cancer: hypoxia-induced noncoding ultraconserved transcriptsJ Ferdin, N Nishida, X Wu, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 22, 2015
Serum Fractalkine (CX3CL1) and Cardiovascular Outcomes and Diabetes: Findings From the Chronic Renal Insufficiency Cohort (CRIC) StudyRachana Shah, Gregory J Matthews, Rhia Y Shah, et al.
European Urology Focus|March 2, 2023
Cytoreductive Nephrectomy for Patients with Metastatic Sarcomatoid and/or Rhabdoid Renal Cell Carcinoma Treated with Immune Checkpoint TherapyAndrew W Hahn, Ritesh R Kotecha, Paul V Viscuse, et al.
The New England Journal of Medicine|June 15, 2026
Lonvoguran Ziclumeran - In Vivo CRISPR Gene Editing in Hereditary AngioedemaDanny M Cohn, Padmalal Gurugama, Hilary J Longhurst, et al.
Pageof 30

Showing results (261-270 of 296) with videos related to

Sort By:
Pageof 30
JCO Precision Oncology|March 30, 2026
Efficacy of Immune Checkpoint Blockade in Advanced Upper Tract Urothelial Cancer With DNA Mismatch Repair Deficiency or Microsatellite InstabilityMohammad Jad Moussa, Alexander Y Andreev-Drakhlin, Aradhana M Venkatesan, et al.
Plos Genetics|September 5, 2014
Histone methyltransferase MMSET/NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylationRelja Popovic, Eva Martinez-Garcia, Eugenia G Giannopoulou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 25, 2025
Final analysis of nivolumab plus cabozantinib for advanced renal cell carcinoma from the randomized phase III CheckMate 9ER trialR J Motzer, B Escudier, M Burotto, et al.
BJU International|November 19, 2016
Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative studyAmishi Y Shah, Jose A Karam, Gabriel G Malouf, et al.
Cancer Medicine|January 20, 2025
Histopathologic Progression and Metastatic Relapse Outcomes in Small Cell Neuroendocrine Carcinomas of the Urinary TractMohammad Jad Moussa, Georges C Tabet, Arlene O Siefker-Radtke, et al.
The Medical Journal of Malaysia|August 20, 2019
Administration of tranexamic acid for victims of severe trauma within pre-hospital care ambulance services (PHCAS) in MalaysiaM Y Shah Jahan, M A Shamila, N Nurul Azlean, et al.
Cell Death and Differentiation|September 17, 2013
HINCUTs in cancer: hypoxia-induced noncoding ultraconserved transcriptsJ Ferdin, N Nishida, X Wu, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 22, 2015
Serum Fractalkine (CX3CL1) and Cardiovascular Outcomes and Diabetes: Findings From the Chronic Renal Insufficiency Cohort (CRIC) StudyRachana Shah, Gregory J Matthews, Rhia Y Shah, et al.
European Urology Focus|March 2, 2023
Cytoreductive Nephrectomy for Patients with Metastatic Sarcomatoid and/or Rhabdoid Renal Cell Carcinoma Treated with Immune Checkpoint TherapyAndrew W Hahn, Ritesh R Kotecha, Paul V Viscuse, et al.
The New England Journal of Medicine|June 15, 2026
Lonvoguran Ziclumeran - In Vivo CRISPR Gene Editing in Hereditary AngioedemaDanny M Cohn, Padmalal Gurugama, Hilary J Longhurst, et al.
Pageof 30